These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. Mehran R; Brodie B; Cox DA; Grines CL; Rutherford B; Bhatt DL; Dangas G; Feit F; Ohman EM; Parise H; Fahy M; Lansky AJ; Stone GW Am Heart J; 2008 Jul; 156(1):44-56. PubMed ID: 18585496 [TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. Cohen DJ; Lincoff AM; Lavelle TA; Chen HL; Bakhai A; Berezin RH; Jackman D; Sarembock IJ; Topol EJ J Am Coll Cardiol; 2004 Nov; 44(9):1792-800. PubMed ID: 15519009 [TBL] [Abstract][Full Text] [Related]
7. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Stone GW; White HD; Ohman EM; Bertrand ME; Lincoff AM; McLaurin BT; Cox DA; Pocock SJ; Ware JH; Feit F; Colombo A; Manoukian SV; Lansky AJ; Mehran R; Moses JW; Lancet; 2007 Mar; 369(9565):907-19. PubMed ID: 17368152 [TBL] [Abstract][Full Text] [Related]
8. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. Marzocchi A; Piovaccari G; Manari A; Aurier E; Benassi A; Saia F; Casella G; Varani E; Santarelli A; Guastaroba P; Grilli R; Maresta A Am J Cardiol; 2005 Jun; 95(12):1409-14. PubMed ID: 15950561 [TBL] [Abstract][Full Text] [Related]
9. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy. Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ; J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319 [TBL] [Abstract][Full Text] [Related]
11. Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions. Kao J; Lincoff AM; Topol EJ; Madrid A; J Price M; Sawhney N; Teirstein PS Catheter Cardiovasc Interv; 2006 Sep; 68(3):352-6. PubMed ID: 16892428 [TBL] [Abstract][Full Text] [Related]
12. What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice? Brodie BR Catheter Cardiovasc Interv; 2008 May; 71(6):816-21. PubMed ID: 18412079 [TBL] [Abstract][Full Text] [Related]
13. Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Exaire JE; Butman SM; Ebrahimi R; Kleiman NS; Harrington RA; Schweiger MJ; Bittl JA; Wolski K; Topol EJ; Lincoff AM; Am Heart J; 2006 Jul; 152(1):157-63. PubMed ID: 16824849 [TBL] [Abstract][Full Text] [Related]
14. Addition of heparin to contrast media is associated with increased bleeding and peripheral vascular complications during percutaneous coronary intervention with bivalirudin and drug-eluting stents. Rha SW; Kuchulakanti PK; Pakala R; Cheneau E; Pinnow E; Gebreeyesus A; Aggrey G; Pichard AD; Satler LF; Kent KM; Lindsay J; Waksman R Cardiovasc Radiat Med; 2004; 5(2):64-70. PubMed ID: 15464942 [TBL] [Abstract][Full Text] [Related]
15. Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results. Mishkel GJ; Moore AL; Markwell SJ; Ligon RW J Invasive Cardiol; 2007 Feb; 19(2):63-8. PubMed ID: 17268039 [TBL] [Abstract][Full Text] [Related]